What is the main business of Solpharm?

The main business activity of Solpharm focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on June 19, 2002.

Where is the headquarters located?

The headquarters is located at: ul. Zakątek 1, 05-270 Marki.

What is the share capital?

The share capital of the company is PLN 445,500 (approx. $120,340).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

The company reported a revenue of $6,142,617 in 2025, which is an increase of 34.6% compared to 2024.

Is the company profitable?

Yes, the company recorded a net profit of $449,009 in 2025, meaning the company increased its profit by 26.5%.

What is the main operating cost?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $2,887,493 in 2025, representing 52% of all operating expenses.

Solpharmsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2002-06-19

Share capital

445,500.00 PLN

Activity description

Solpharm is a Polish pharmaceutical company and wholesaler with a 25-year history, specializing in the sale of specialist pharmaceutical products. It works with European manufacturers to supply medicines and medical devices for dermatology, pediatrics, and long-term care.

Registered address

ul. Zakątek 1, 05-270 Marki, Poland

Website

solpharm.pl

Phone

Social media

Electronic delivery address

AE:PL-40321-36381-IVCHH-21

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 134 days early.

202513/03/2026
202418/03/2025
202313/03/2024
202215/03/2023
202127/04/2022
202019/02/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 6.14mMedianUSD 1.06mAverageUSD 22.40m

Net profit

This companyUSD 449.01kMedianUSD 37.33kAverageUSD 880.24k

Operating costs

This companyUSD 5.56mMedianUSD 922.77kAverageUSD 21.08m

Assets

This companyUSD 3.42mMedianUSD 608.93kAverageUSD 11.85m

Industry

Trademarks

Solpharm holds 7 active trademarks registered with the Polish Patent Office. 1 application is pending. 2 marks have expired or were not registered. The first mark was filed in 2001.

Mark	Number	Classes	Status	Protected until
bocaDERMIC	Z.586605	3	Protected	Jun 25, 2035
SELFIE DERMIC	Z.554453	3	Protected	Apr 3, 2033
SZYBKA DWÓJKA na zaparcia	Z.525840	5	Protected	Mar 9, 2031
Soltopin(word)	Z.498496	3, 5	Protected	Apr 9, 2029
LEKKO, bez zaparć!	Z.482268	5	Protected	Feb 12, 2028

Mark	Protected until
bocaDERMIC	Jun 25, 2035
SELFIE DERMIC	Apr 3, 2033
SZYBKA DWÓJKA na zaparcia	Mar 9, 2031
Soltopin(word)	Apr 9, 2029
LEKKO, bez zaparć!	Feb 12, 2028

Authorized Representatives

Anna Kutyna Plechanow – President of the Management Board

Jerzy Plechanow – Management Board Member

Kamil Leduchowski – Management Board Member

Sebastian Kutyna Plechanow – Management Board Member

Marta Najri Leduchowska – Management Board Member

Manner of representation

For making declarations of will concerning the company's proprietary and non-proprietary rights and obligations and for signing on behalf of the company, the following are authorised: the President of the Management Board acting independently, the Vice-President of the Management Board acting independently, two members of the management board acting jointly, or a member of the management board acting jointly with a commercial proxy, if appointed.

Ownership

Owner	Shares	Share value	Stake
Anna Seda Kutyna Plechanowage 48	223	$30,118.85	25.0281%
Marta Najri Leduchowskaage 44	178	$24,041.06	19.9776%
Jerzy Plechanowage 73	490	$66,180.44	54.9944%

Jerzy Plechanow and Anna Seda Kutyna Plechanow hold a combined 80% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2002-12-10.

mBank
12 1140 1010 0000 2820 0200 1029
mBank
62 1140 1010 0000 2820 0200 1002
mBank
89 1140 1010 0000 2820 0200 1001

Debt

No entries in the National Debtors Register (KRZ).

Real estate

Type	Amount
Buildings and premises	PLN 249.4KPLN 249,398

Public aid

8 public aid cases recorded, with a total value of $67,344.

Grant date	Purpose	Gross amount	Granting body
Jul 30, 2026	De minimis aid (in accordance with Commission Regulation 2023/2831)	$14,992$14,992	Starosta Wołomiński
Jan 7, 2026	De minimis aid (in accordance with Commission Regulation 2023/2831)	$456$456	PGE Obrót S.A.
Aug 21, 2025	De minimis aid (in accordance with Commission Regulation 2023/2831)	$12,054$12,054	Prezes Banku Gospodarstwa Krajowego

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

Name	Revenue	Website
Ursapharm Polandsp. z o.o.	$16,296,973.60	ursapharm.pl
Pharmabestsp. z o.o.	$13,942,252.57	pharmabest.pl
PolypharmS.A.	$13,660,727.48	polypharm.pl
Domesthicsp. z o.o.	$13,615,471.93	domesthic.pl
Interpharmasp. z o.o.	$12,321,125.25	interpharma.com.pl
Trade-Pharmsp. z o.o.	$9,043,325.21	tradepharm.com.pl
Pharm Supplysp. z o.o.	$6,901,751.00	pharmsupply.com.pl
Polmilsp. z o.o.	$6,332,250.91	polmil.pl
Albert Polskasp. z o.o.	$5,189,571.80	albert.com.pl
Farmbudsp. z o.o.	$2,476,637.88	farmbud.eu

Change history

Date	Event
2019-01-04	Address change (Zwycięzców 42/93, 03-938, Warszawa → Ul. Zakątek 1, 05-270, Marki)
2013-11-18	Share capital increase (262,500.00 PLN → 445,500.00 PLN)
2003-01-17	Share capital increase (50,000.00 PLN → 262,500.00 PLN)
2002-09-11	Address change (Zwycięzców 42/93, 03-928, Warszawa → Zwycięzców 42/93, 03-938, Warszawa)
2002-08-09	Address change (Zwycięzców 42, 03-938, Warszawa → Zwycięzców 42/93, 03-928, Warszawa)

FAQ

Last updated: 2026-04-05